APA (7th ed.) Citation

W, F., S, B., N, D., CP, M., K, S., CE, B., . . . KN, B. (2022). Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c). Blood cancer journal, 12(1), 5. https://doi.org/10.1038/s41408-021-00603-3

Chicago Style (17th ed.) Citation

W, Fiskus, et al. "Effective Menin Inhibitor-based Combinations Against AML with MLL Rearrangement or NPM1 Mutation (NPM1c)." Blood Cancer Journal 12, no. 1 (2022): 5. https://doi.org/10.1038/s41408-021-00603-3.

MLA (9th ed.) Citation

W, Fiskus, et al. "Effective Menin Inhibitor-based Combinations Against AML with MLL Rearrangement or NPM1 Mutation (NPM1c)." Blood Cancer Journal, vol. 12, no. 1, 2022, p. 5, https://doi.org/10.1038/s41408-021-00603-3.